BioTelemetry (BEAT) Tops Q1 EPS by 1c; Raises Revenue Otulook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
April 25, 2019 4:05 PM EDTAchieves Record Quarterly Revenue
Raises Full Year 2019 Guidance
MALVERN, Pa., April 25, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2019.
Quarter Highlights
Recognized record quarterly revenue of $104.0 millionReached 10.0% year-over-year revenue growthAchieved 27th consecutive quarter of year-over-year revenue growthReported GAAP net income of $11.7 millionRealized quarterly adjusted EBITDA of $28.8 million, or 27.7% of... More